Orthofix International | OFIX - Loan Capital


Orthofix International reported $221.33M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Accuray USD 127.32M 3.53M Sep/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 217.81M 2.94M Dec/2025
AtriCure USD 61.86M 0 Dec/2025
Dexcom USD 1.3B 54.4M Mar/2026
EDAP TMS EUR 1.01M 13K Sep/2025
Globus Medical USD 436K 9K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Orthofix International USD 221.33M 46.88M Mar/2026
Plus Therapeutics USD 3.79M 322K Dec/2022
Smith & Nephew USD 3.3B 22M Dec/2025
STAAR Surgical USD 42K 42K Dec/2023
Stryker USD 14.22B 635M Mar/2026
Surmodics USD 29.67M 116K Jun/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Veracyte USD 0 0 Mar/2025
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026